Company | Name | Exchange | Sector | Industry | Market Cap | P/E Ratio | PEG Ratio | Last Trade Price | Day Change (%) | Fair Value | Fair Value Upside | Fair Value Label | Analyst Price Target | Analyst Target Upside | Overall Health |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Ryvu | Warsaw | Healthcare | Biotechnology & Medical Research | PLN 694.76M | -6.2x | 0.22 | PLN 30.05 | 1.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Selvita | Warsaw | Healthcare | Biotechnology & Medical Research | PLN 513.95M | -122.1x | 0.97 | PLN 28 | 1.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Scope Fluidics | Warsaw | Healthcare | Biotechnology & Medical Research | PLN 403.98M | 6.8x | 0.02 | PLN 148.20 | -0.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Captor Therapeutics | Warsaw | Healthcare | Biotechnology & Medical Research | PLN 185.76M | -3.9x | -0.1 | PLN 33.60 | -1.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Poltreg | Warsaw | Healthcare | Biotechnology & Medical Research | PLN 159.96M | -7.8x | 0.23 | PLN 34.30 | -0.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Mabion | Warsaw | Healthcare | Biotechnology & Medical Research | PLN 156.45M | -4x | 0.02 | PLN 9.68 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -12.2% Downside | Upgrade to Pro+ | |
Molecure | Warsaw | Healthcare | Biotechnology & Medical Research | PLN 120.01M | -5.9x | -0.25 | PLN 5.94 | -4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Genomtec | Warsaw | Healthcare | Biotechnology & Medical Research | PLN 101.69M | -9.1x | 1.9 | PLN 6.84 | -1.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Nanogroup | Warsaw | Healthcare | Biotechnology & Medical Research | PLN 88.90M | -16.9x | -0.28 | PLN 2.81 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Urteste | Warsaw | Healthcare | Biotechnology & Medical Research | PLN 75.84M | -24.3x | -0.54 | PLN 53.80 | 2.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Readgene | Warsaw | Healthcare | Biotechnology & Medical Research | PLN 55.88M | -79.4x | -1.64 | PLN 4.74 | 6.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Sygnis | Warsaw | Healthcare | Biotechnology & Medical Research | PLN 43.67M | PLN 1.73 | 8.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||||
Genomed | Warsaw | Healthcare | Biotechnology & Medical Research | PLN 34.35M | 16.8x | 0.05 | PLN 26 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Sds Optic | Warsaw | Healthcare | Biotechnology & Medical Research | PLN 26.11M | PLN 4.40 | 2.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||||
Medicofarma Biotech | Warsaw | Healthcare | Biotechnology & Medical Research | PLN 18.35M | -6.3x | 1.41 | PLN 0.27 | -1.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Stem Cells Spin | Warsaw | Healthcare | Biotechnology & Medical Research | PLN 9.26M | -17.8x | 0.12 | PLN 0.22 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ |